Mayo Stephen

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 7% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mayo Stephen's trades of Sarepta Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
256.71
Quantity 18,782
Value US$3,555,029
Transaction date
Proposed sale
Price
122.96
Quantity 3,135
Value US$385,482
Transaction date
Proposed sale
Price
4.29
Quantity 10,000
Value US$42,855
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-13 2026-03-12
S Sale
30,114 -19.6%
409.64
US$1,329,161 		30,114 -19.6% 409.64 US$1,329,161
2026-03-12 2026-03-12
PrS Proposed sale
18,782
256.71
US$3,555,029 		18,782 256.71 US$3,555,029
2024-03-06 2024-03-05
S Sale
17,916 +32.1%
187.35
US$632,927 		17,916 +32.1% 187.35 US$632,927
2024-03-05 2024-03-05
PrS Proposed sale
3,135
122.96
US$385,482 		3,135 122.96 US$385,482
2023-08-09 2023-08-07
S Sale
10,000 -28.3%
4.29
US$42,855 		10,000 -28.3% 4.29 US$42,855
2023-08-07 2023-08-07
PrS Proposed sale
10,000
4.29
US$42,855 		10,000 4.29 US$42,855
2022-11-21 2022-11-17
S Sale
858 -11.8%
109.92
US$94,311 		858 -11.8% 109.92 US$94,311